Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 128

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 128
---
registered public accounting firm, and submit to the SEC, on a Form 6-K, unaudited quarterly financial information.

We maintain a corporate website at https://nlspharma.com.
The SEC also maintains a web site that contains information we file electronically with the SEC, which you can access over the Internet
at http://www.sec.gov. Information contained on, or that can be accessed through, our website and other websites listed in this prospectus
do not constitute a part of this prospectus. We have included these website addresses in this prospectus solely as inactive textual references.

This prospectus is part of a registration statement
on Form F-3 filed by us with the SEC under the Securities Act. As permitted by the rules and regulations of the SEC, this prospectus does
not contain all the information set forth in the registration statement and the exhibits thereto filed with the SEC. For further information
with respect to us and the Common Shares offered hereby, you should refer to the complete registration statement on Form F-3, which may
be obtained from the locations described above. Statements contained in this prospectus or in any prospectus supplement about the contents
of any contract or other document are not necessarily complete. If we have filed any contract or other document as an exhibit to the registration
statement or any other document incorporated by reference in the registration statement, you should read the exhibit for a more complete
understanding of the document or matter involved. Each statement regarding a contract or other document is qualified in its entirety by
reference to the actual document.

<div align='center'>88

ENFORCEABILITY OF CIVIL LIABILITIES</div>

We are incorporated under
the laws of Switzerland and our registered office and domicile is located in Kloten (Zurich), Switzerland. Moreover, a majority of our
directors and senior management are not residents of the United States, and all or a substantial portion of our assets are located outside
the United States. As a result, it may not be possible for investors to effect service of process within the United States upon us or
upon such persons or to enforce against them judgments obtained in U.S. courts, including judgments in actions predicated upon the civil
liability provisions of the federal securities laws of the United States.

We have been advised by our
Swiss counsel that there is doubt as to the enforceability in Switzerland of original actions, or in actions for enforcement of judgments
of U.S. courts, of civil liabilities to the extent pred